DEJIMA Infectious Disease Research Alliance (DIDA)
Nagasaki University
EN
JP
Home
About DIDA
From the President of Nagasaki University
From the Director of DIDA
Organization
Tokyo Office
Vaccine Research and Development Center
Home
About DIDA
From the President of Nagasaki University
From the Director of DIDA
Organization
Tokyo Office
Vaccine Research and Development Center
EN
JP
Nagasaki Dejima Illustration, drawn by KAWAHARA Keiga:owned by the Nagasaki University Library
Scroll
Topics
2026.2.4
Vaccine Research and Development Center
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on「The benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling study」 22026/1/20
2026.2.4
Vaccine Research and Development Center
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on「Non-Vaccine Serotype Replacement and Subdominant Persistence of Vaccine Types in Nepalese Infants Following PCV10 Introduction」 2026/1/8
2026.2.4
Vaccine Research and Development Center
Research Highlights
Highly Pathogenic Virus Therapeutics Development Team:Announcement on「Identification of claramine and anidulafungin as entry inhibitors of Crimean–Congo hemorrhagic fever virus」 2026/1/8
2026.2.4
Vaccine Research and Development Center
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on「Burden of typhoid fever and antimicrobial resistance in India (2023): a modelling study」 2026/1/7
2026.2.4
Vaccine Research and Development Center
Research Highlights
Highly Pathogenic Virus Therapeutics Development Team:Announcement on「Remdesivir as a potent antiviral against prototype and current epidemic Oropouche virus strains (BeAn19991 and PE-IAM4637)」 2025/12/19
View all
2025.4.7
News
Professor Koichi Morita Receives the “For People’s Health” Medal from Vietnam’s Ministry of Health
2025.3.10
Nagasaki University Secures CEPI Funding to Develop AI-Driven Nanoball Vaccine Technology – Targeting mRNA Vaccine for Severe Fever with Thrombocytopenia Syndrome (SFTS)
2025.3.5
News
Visit from Sukraraj Tropical and Infectious Disease Hospital (STIDH), Kathmandu, Nepal
2024.3.12
Nagasaki University signed an MOU with the International Vaccine Institute (IVI)
2022.9.27
News
Events
Nagasaki University held a launching ceremony for the DEJIMA Infectious Disease Research Alliance and the National Research Center for the Control and Prevention of Infectious Diseases.
View all
2026.2.4
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on「The benefits and risks of maternal RSV vaccination on mortality in South Africa: A modeling study」 22026/1/20
2026.2.4
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on「Non-Vaccine Serotype Replacement and Subdominant Persistence of Vaccine Types in Nepalese Infants Following PCV10 Introduction」 2026/1/8
2026.2.4
Research Highlights
Highly Pathogenic Virus Therapeutics Development Team:Announcement on「Identification of claramine and anidulafungin as entry inhibitors of Crimean–Congo hemorrhagic fever virus」 2026/1/8
2026.2.4
Research Highlights
Infectious Disease Medical Epidemiology Team:Announcement on「Burden of typhoid fever and antimicrobial resistance in India (2023): a modelling study」 2026/1/7
2026.2.4
Research Highlights
Highly Pathogenic Virus Therapeutics Development Team:Announcement on「Remdesivir as a potent antiviral against prototype and current epidemic Oropouche virus strains (BeAn19991 and PE-IAM4637)」 2025/12/19
View all
PAGE TOP